Estrategias de control avanzadas para páncreas artificial

Autores
Fushimi, Emilia
Año de publicación
2021
Idioma
español castellano
Tipo de recurso
tesis doctoral
Estado
versión aceptada
Colaborador/a o director/a de tesis
Garelli, Fabricio
De Battista, Hernán
Descripción
Artificial Pancreas (AP) systems consist on a subcutaneous insulin pump connected to a continuous glucose monitor (CGM) through a control algorithm that calculates the appropriate insulin dose according to CGM readings. Though great research has been carried in this topic, there are still many limitations that make full closed-loop glycemic control challenging. These limitations include large delays in CGM readings and in the insulin action, intra and inter-patient variability, and the fact that there is no negative action to counteract insulin, among others. Here, several steps towards full closed-loop control are taken. First, hypoglycemia is mitigated using constant and time-varying IOB constraints in hybrid-loop and closed-loop controllers with meal announcement. Then, a switching signal generator is proposed in order to enable automatic switching between closed-loop controllers in a switched control scheme, thus eliminating the need for meal announcement. Lastly, a dual-hormone controller is presented in order to improve the performance achieved by a fully closed-loop, single-hormone control algorithm. Also, in the context of the COVID 19 pandemic, a remote monitoring platform is employed in order to monitor patients in the intensive care unit, thus reducing healthcare profesional exposure. Then, a closed-loop algorithm is tested in the first ambulatory artificial pancreas clinical trials in Argentina.
Doctor en Ingeniería
Universidad Nacional de La Plata
Facultad de Ingeniería
Materia
Ingeniería
Diabetes Mellitus Tipo 1
Páncreas Artificial
Control Automático
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by-nc-nd/4.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/133534

id SEDICI_f927c2c61004fb3685c184c2b7ae9d6e
oai_identifier_str oai:sedici.unlp.edu.ar:10915/133534
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling Estrategias de control avanzadas para páncreas artificialFushimi, EmiliaIngenieríaDiabetes Mellitus Tipo 1Páncreas ArtificialControl AutomáticoArtificial Pancreas (AP) systems consist on a subcutaneous insulin pump connected to a continuous glucose monitor (CGM) through a control algorithm that calculates the appropriate insulin dose according to CGM readings. Though great research has been carried in this topic, there are still many limitations that make full closed-loop glycemic control challenging. These limitations include large delays in CGM readings and in the insulin action, intra and inter-patient variability, and the fact that there is no negative action to counteract insulin, among others. Here, several steps towards full closed-loop control are taken. First, hypoglycemia is mitigated using constant and time-varying IOB constraints in hybrid-loop and closed-loop controllers with meal announcement. Then, a switching signal generator is proposed in order to enable automatic switching between closed-loop controllers in a switched control scheme, thus eliminating the need for meal announcement. Lastly, a dual-hormone controller is presented in order to improve the performance achieved by a fully closed-loop, single-hormone control algorithm. Also, in the context of the COVID 19 pandemic, a remote monitoring platform is employed in order to monitor patients in the intensive care unit, thus reducing healthcare profesional exposure. Then, a closed-loop algorithm is tested in the first ambulatory artificial pancreas clinical trials in Argentina.Doctor en IngenieríaUniversidad Nacional de La PlataFacultad de IngenieríaGarelli, FabricioDe Battista, Hernán2021-12-10info:eu-repo/semantics/doctoralThesisinfo:eu-repo/semantics/acceptedVersionTesis de doctoradohttp://purl.org/coar/resource_type/c_db06info:ar-repo/semantics/tesisDoctoralapplication/pdfhttp://sedici.unlp.edu.ar/handle/10915/133534https://doi.org/10.35537/10915/133534spainfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-29T11:33:36Zoai:sedici.unlp.edu.ar:10915/133534Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-29 11:33:36.659SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv Estrategias de control avanzadas para páncreas artificial
title Estrategias de control avanzadas para páncreas artificial
spellingShingle Estrategias de control avanzadas para páncreas artificial
Fushimi, Emilia
Ingeniería
Diabetes Mellitus Tipo 1
Páncreas Artificial
Control Automático
title_short Estrategias de control avanzadas para páncreas artificial
title_full Estrategias de control avanzadas para páncreas artificial
title_fullStr Estrategias de control avanzadas para páncreas artificial
title_full_unstemmed Estrategias de control avanzadas para páncreas artificial
title_sort Estrategias de control avanzadas para páncreas artificial
dc.creator.none.fl_str_mv Fushimi, Emilia
author Fushimi, Emilia
author_facet Fushimi, Emilia
author_role author
dc.contributor.none.fl_str_mv Garelli, Fabricio
De Battista, Hernán
dc.subject.none.fl_str_mv Ingeniería
Diabetes Mellitus Tipo 1
Páncreas Artificial
Control Automático
topic Ingeniería
Diabetes Mellitus Tipo 1
Páncreas Artificial
Control Automático
dc.description.none.fl_txt_mv Artificial Pancreas (AP) systems consist on a subcutaneous insulin pump connected to a continuous glucose monitor (CGM) through a control algorithm that calculates the appropriate insulin dose according to CGM readings. Though great research has been carried in this topic, there are still many limitations that make full closed-loop glycemic control challenging. These limitations include large delays in CGM readings and in the insulin action, intra and inter-patient variability, and the fact that there is no negative action to counteract insulin, among others. Here, several steps towards full closed-loop control are taken. First, hypoglycemia is mitigated using constant and time-varying IOB constraints in hybrid-loop and closed-loop controllers with meal announcement. Then, a switching signal generator is proposed in order to enable automatic switching between closed-loop controllers in a switched control scheme, thus eliminating the need for meal announcement. Lastly, a dual-hormone controller is presented in order to improve the performance achieved by a fully closed-loop, single-hormone control algorithm. Also, in the context of the COVID 19 pandemic, a remote monitoring platform is employed in order to monitor patients in the intensive care unit, thus reducing healthcare profesional exposure. Then, a closed-loop algorithm is tested in the first ambulatory artificial pancreas clinical trials in Argentina.
Doctor en Ingeniería
Universidad Nacional de La Plata
Facultad de Ingeniería
description Artificial Pancreas (AP) systems consist on a subcutaneous insulin pump connected to a continuous glucose monitor (CGM) through a control algorithm that calculates the appropriate insulin dose according to CGM readings. Though great research has been carried in this topic, there are still many limitations that make full closed-loop glycemic control challenging. These limitations include large delays in CGM readings and in the insulin action, intra and inter-patient variability, and the fact that there is no negative action to counteract insulin, among others. Here, several steps towards full closed-loop control are taken. First, hypoglycemia is mitigated using constant and time-varying IOB constraints in hybrid-loop and closed-loop controllers with meal announcement. Then, a switching signal generator is proposed in order to enable automatic switching between closed-loop controllers in a switched control scheme, thus eliminating the need for meal announcement. Lastly, a dual-hormone controller is presented in order to improve the performance achieved by a fully closed-loop, single-hormone control algorithm. Also, in the context of the COVID 19 pandemic, a remote monitoring platform is employed in order to monitor patients in the intensive care unit, thus reducing healthcare profesional exposure. Then, a closed-loop algorithm is tested in the first ambulatory artificial pancreas clinical trials in Argentina.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-10
dc.type.none.fl_str_mv info:eu-repo/semantics/doctoralThesis
info:eu-repo/semantics/acceptedVersion
Tesis de doctorado
http://purl.org/coar/resource_type/c_db06
info:ar-repo/semantics/tesisDoctoral
format doctoralThesis
status_str acceptedVersion
dc.identifier.none.fl_str_mv http://sedici.unlp.edu.ar/handle/10915/133534
https://doi.org/10.35537/10915/133534
url http://sedici.unlp.edu.ar/handle/10915/133534
https://doi.org/10.35537/10915/133534
dc.language.none.fl_str_mv spa
language spa
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-nd/4.0/
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1844616216043323392
score 13.070432